Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Brain Res ; 1583: 132-40, 2014 Oct 02.
Artigo em Inglês | MEDLINE | ID: mdl-25108041

RESUMO

Angiotensin II (Ang II) stimulates water and saline intakes when injected into the brain of rats. This arises from activation of the AT1 Ang II receptor subtype. Acute repeated injections, however, decrease the water intake response to Ang II without affecting saline intake. Previous studies provide evidence that Ang II-induced water intake is mediated via the classical G protein coupling pathway, whereas the saline intake caused by Ang II is mediated by an ERK 1/2 MAP kinase signaling pathway. Accordingly, the different behavioral response to repeated injections of Ang II may reflect a selective effect on G protein coupling. To test this hypothesis, we examined the binding of a radiolabeled agonist ((125)I-sarcosine(1) Ang II) and a radiolabeled antagonist ((125)I-sarcosine(1), isoleucine(8) Ang II) in brain homogenates and tissue sections prepared from rats given repeated injections of Ang II or vehicle. Although no treatment-related differences were found in hypothalamic homogenates, a focus on specific brain structures using receptor autoradiography, found that the desensitization treatment reduced binding of both radioligands in the paraventricular nucleus of the hypothalamus (PVN) and median preoptic nucleus (MnPO), but not in the subfornical organ (SFO). Because G protein coupling is reported to have a selective effect on agonist binding without affecting antagonist binding, these findings do not support a G protein uncoupling treatment effect. This suggests that receptor number is more critical to the water intake response than the saline intake response, or that pathways downstream from the G protein mediate desensitization of the water intake response.


Assuntos
Angiotensina II/farmacologia , Fármacos do Sistema Nervoso Central/farmacologia , Núcleo Hipotalâmico Paraventricular/efeitos dos fármacos , Área Pré-Óptica/efeitos dos fármacos , 1-Sarcosina-8-Isoleucina Angiotensina II/metabolismo , Angiotensina II/administração & dosagem , Angiotensina II/análogos & derivados , Angiotensina II/metabolismo , Bloqueadores do Receptor Tipo 1 de Angiotensina II/metabolismo , Bloqueadores do Receptor Tipo 2 de Angiotensina II/metabolismo , Animais , Ingestão de Líquidos/efeitos dos fármacos , Ingestão de Líquidos/fisiologia , Água Potável/administração & dosagem , Radioisótopos do Iodo , Masculino , Núcleo Hipotalâmico Paraventricular/metabolismo , Área Pré-Óptica/fisiopatologia , Ensaio Radioligante , Compostos Radiofarmacêuticos , Ratos Sprague-Dawley , Receptor Tipo 2 de Angiotensina/agonistas , Receptor Tipo 2 de Angiotensina/metabolismo , Cloreto de Sódio na Dieta/administração & dosagem , Órgão Subfornical/efeitos dos fármacos , Órgão Subfornical/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...